Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Abstract Background LYRM4 is necessary to maintain the stability and activity of the human cysteine desulfurase complex NFS1-LYRM4-ACP. The existing experimental results indicate that cancer cells rely on the high expression of NFS1. However, the role of LYRM4 in liver hepatocellular carcinoma (LIHC...

Full description

Bibliographic Details
Main Authors:	Yilin Pang, Guoqiang Tan, Xunjun Yang, Yuanshan Lin, Yao Chen, Jinping Zhang, Ting Xie, Huaibin Zhou, Jun Fang, Qiongya Zhao, Xiaojun Ren, Jianghui Li, Jianxin Lyu, Zheng Wang
Format:	Article
Language:	English
Published:	BMC 2021-09-01
Series:	Cancer Cell International
Subjects:	LYRM4 Hepatocellular carcinoma Prognosis Diagnostic biomarker Functional network analysis
Online Access:	https://doi.org/10.1186/s12935-021-02131-3

Similar Items

LYRM1, a Gene that Promotes Proliferation and Inhibits Apoptosis during Heart Development
by: Ling-Mei Qian, et al.
Published: (2010-10-01)

Iron‐sulfur cluster ISD11 deficiency (LYRM4 gene) presenting as cardiorespiratory arrest and 3‐methylglutaconic aciduria
by: Margarida Paiva Coelho, et al.
Published: (2019-09-01)

Exosomes Isolated From Bone Marrow Mesenchymal Stem Cells Exert a Protective Effect on Osteoarthritis via lncRNA LYRM4-AS1-GRPR-miR-6515-5p
by: Xiuhui Wang, et al.
Published: (2021-05-01)

Mitochondrial OXPHOS Biogenesis: Co-Regulation of Protein Synthesis, Import, and Assembly Pathways
by: Jia Xin Tang, et al.
Published: (2020-05-01)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
by: Yao Chen, et al.
Published: (2021-05-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Shanshan Liu, et al.
Published: (2021-09-01)

Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma
by: Yulong Chen, et al.
Published: (2021-05-01)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
by: Cai, J., et al.
Published: (2022)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
by: Danjun Song, et al.
Published: (2020-07-01)

Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma
by: Tiantian Liu, et al.
Published: (2020-10-01)

Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma
by: Xiaopu Sang, et al.
Published: (2020-02-01)

A novel RNA sequencing‐based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma
by: Fumao Bai, et al.
Published: (2018-06-01)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
by: Xingwei Xie, et al.
Published: (2021-03-01)

Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
by: Hao Xu, et al.
Published: (2021-01-01)

Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma
by: Qianhui Xu, et al.
Published: (2021-09-01)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
by: Chenxi Ma, et al.
Published: (2020-12-01)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
by: Yongkang Wang, et al.
Published: (2021-02-01)

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma
by: Jiawei Rao, et al.
Published: (2020-10-01)

Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
by: Long S, et al.
Published: (2021-09-01)

Contrast-enhanced ultrasound in the diagnosis of infiltrative hepatocellular carcinoma: A report of three cases
by: Yasovineeth Bhogadi, BSc, et al.
Published: (2021-03-01)

Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma
by: Xiaobo Wang, et al.
Published: (2021-09-01)

Essential role of accessory subunit LYRM6 in the mechanism of mitochondrial complex I
by: Etienne Galemou Yoga, et al.
Published: (2020-11-01)

Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma
by: Xiaoqin Zheng, et al.
Published: (2021-09-01)

Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma
by: Zhang Z, et al.
Published: (2021-08-01)

Prognostic Signature of Hepatocellular Carcinoma and Analysis of Immune Infiltration Based on m6A-Related lncRNAs
by: Ting Guo, et al.
Published: (2021-08-01)

Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma
by: Lijuan Li, et al.
Published: (2021-01-01)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
by: Meng-Xin Tian, et al.
Published: (2019-06-01)

DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma
by: Guo Y, et al.
Published: (2021-08-01)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
by: Zhangya Pu, et al.
Published: (2021-05-01)

Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
by: Zi-shu Zhang, et al.
Published: (2019-11-01)

Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
by: Juanni Li, et al.
Published: (2021-01-01)

Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas
by: Yi-Wen Hsiao, et al.
Published: (2019-08-01)

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
by: Zakka K, et al.
Published: (2019-07-01)

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma
by: Jihao Cai, et al.
Published: (2021-08-01)

Case report of a lymphoepithelioma-like hepatocellular carcinoma with prominent lymphoplasmacytic infiltration
by: Hirotsugu Noguchi, et al.
Published: (2020-09-01)

In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma
by: Wenbiao Chen, et al.
Published: (2020-01-01)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
by: Lu Yin, et al.
Published: (2021-02-01)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
by: Yuan Nie, et al.
Published: (2021-03-01)

Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021-03-01)